No longer young, debatably more mature, but definitely older looking than the photograph below, David Healy figures he might now be able to deliver a decent lecture. He's been invited to speak at an International Society for Ethical Psychology and Psychiatry in 2 weeks time - on October 28. The talk will cover some of the points mentioned in the last post - Psychotropic … [Read more...] about Random or Mad
The Lasagna Series
When does Yes mean No
Editorial Note: This is the ninth piece or final third of the final triptych in the Lasagna trilogy of triptychs that started with Not So Bad Pharma and runs through to Marilyn's Curse. Marilyn died of an overdose of barbiturate sleeping pills (Tragedy). A bystander, Lou Lasagna, noted she had been denied access to a sleeping pill that was safe in overdose, the first pill of … [Read more...] about When does Yes mean No
Marilyn’s Curse
Editorial Note: This an unexpected eighth part to the Lasagna Trilogy that started with Not So Bad Pharma and runs through to Witty A: Report to the President. Ondine Ondine was a nymph whose lover swore that his every waking breath was a testimony to his love of her. Finding him unfaithful, she cursed him – should he fall asleep he would stop breathing. Marilyn died of an … [Read more...] about Marilyn’s Curse
Witty A: Report to the President
Editorial Note: This was to be the last in the Lasagna posts that began with Not So Bad Pharma, April Fool in Harlow, The Tragedy of Lou Lasagna, Empire of Humbug: Bad Pharma, Empire of Humbug 2, and Brand Fascism. But the series will continue into Marilyn's Curse and When does Yes Mean No. Faced with questions about the $3 Billion fine imposed on GSK – is it just the cost of … [Read more...] about Witty A: Report to the President
Brand Fascism
Editorial Note: This is the sixth in the Lasagna series of posts that began with Not So Bad Pharma, April Fool in Harlow, Tragedy of Lou Lasagna, Empire of Humbug: Bad Pharma and will continue through to Witty A: Report to the President. Faced with questions about the $3 Billion fine imposed on GSK – Is it just the cost of doing business? Andrew Witty, GSK's CEO, snapped … [Read more...] about Brand Fascism
The Empire of Humbug: Not So Bad Pharma
Editorial Note: This is the fifth is the Lasagna series of posts that began with Not So Bad Pharma, April Fool in Harlow, The Tragedy of Lou Lasagna, Empire of Humbug: Bad Pharma and will continue through to Brand Fascism and Witty A: Report to the President. In 1954 soon after his article with Beecher put the placebo on the map, Lasagna was recruited from Harvard to Hopkins. … [Read more...] about The Empire of Humbug: Not So Bad Pharma
The Empire of Humbug: Bad Pharma
Editorial Note: This is the fourth in the Lasagna series of posts - Not So Bad Pharma, April Fool in Harlow and Tragedy. It will be followed by The Empire of Humbug: Not so Bad Pharma, Brand Fascism & Witty A: Report to President. The first RCT In 1956, two of the creators of the modern RCT, Lou Lasagna and Michael Shepherd, met. The randomization in randomized placebo … [Read more...] about The Empire of Humbug: Bad Pharma
The Tragedy of Lou Lasagna
Editorial Note: This is the 3rd of 6 posts. The first two are Not So Bad Pharma, & April Fool in Harlow. The rest will be The Empire of Humbug 1 & 2 and Brand Fascism. There is an independent debate on some of the issues, including my writing style, at Hearing Voices on 1boringoldman. In 1956, Lou Lasagna was on his way to being the most famous doctor in the United … [Read more...] about The Tragedy of Lou Lasagna
April Fool in Harlow: Anecdote Fishing in Harlow
This is the second of a series of six posts that began with Not So Bad Pharma and will continue with The Tragedy of Lou Lasagna, The Empire of Humbug 1, The Empire of Humbug 2 & Brand Fascism. To celebrate May Fool's Day last year The Scientist ran an article on Data Diving. This featured the work of Peter Doshi and Tom Jefferson and their efforts to get clinical trial … [Read more...] about April Fool in Harlow: Anecdote Fishing in Harlow
Not So Bad Pharma
The invitation from the London Review of Books to review Ben Goldacre’s Bad Pharma™ reads: “We were unsure, at first, what a review could add that isn't already in the book - scrappy summaries and bits of praise are not for us. The book is of sufficient importance that the main thing is to get someone who knows what they're talking about to present the material confidently.. … [Read more...] about Not So Bad Pharma